Copaifera trapezifolia Hayne occurs in the Atlantic Rainforest, which is considered one of the most important and endangered tropical forests on the planet. Although literature works have described many Copaifera spp., their biological activities remain little known. In the present study, we aimed to evaluate (1) the potential of the hydroalcoholic extract from C. trapezifolia leaves (CTE) to act against the causative agents of tooth decay and apical periodontitis and (2) the cytotoxicity and mutagenicity of CTE to ensure that it is safe for subsequent application. Concerning the tested bacteria, the MIC and the minimum bactericidal concentration of CTE varied between 100 and 400 µg ml À1 . The time-kill assay conducted at a CTE concentration of 100 µg ml À1 evidenced bactericidal activity against Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate) within 72 h. CTE at 200 µg ml À1 inhibited Porphyromonas gingivalis and Peptostreptococcus micros biofilm formation by at least 50 %. A combination of CTE with chlorhexidine dichlorohydrate did not prompt any synergistic effects. The colony-forming assay conducted on V79 cells showed that CTE was cytotoxic at concentrations above 156 µg ml À1 . CTE exerted mutagenic effect on V79 cells, but the micronucleus test conducted on Swiss mice and the Ames test did not reveal any mutagenicity. Therefore, the use of standardized and safe extracts could be an important strategy to develop novel oral care products with antibacterial action. These extracts could also serve as a source of compounds for the discovery of new promising biomolecules.
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INTRODUCTION
Oral diseases affect millions of people worldwide. More than 750 bacterial species occur in the oral cavity. Some of these bacteria underlie oral diseases such as caries and apical periodontitis, which are among the most common bacterial infections in humans (Aas et al., 2005; Palombo, 2011) .
Tooth decay is normally associated with Streptococcus spp., especially Streptococcus mutans and Streptococcus sobrinus, and Lactobacillus spp. Biofilm formation on the tooth surface (dental plaque) is one of the causes of this disease (Hirasawa & Takada, 2002; Chung et al., 2006) . Apical periodontitis is an inflammatory reaction to the presence of bacteria within the root canal system. Inflammation emerges in the periapical tissues and may result in tooth loss if left untreated (Peciuliene et al., 2008) . Bacterial species frequently detected in acute and chronic apical periodontitis belong to diverse genera of Gram-negative (Fusobacterium, Dialister, Porphyromonas, Prevotella, Tannerella, Treponema, Campylobacter and Veillonella) and Gram-positive (Parvimonas, Filifactor, Pseudoramibacter, Olsenella, Actinomyces, Peptostreptococcus, Streptococcus, Propionibacterium and Eubacterium) bacteria (Siqueira & Rôças, 2009) .
Oral diseases such as tooth decay and apical periodontitis impact people's health negatively -they diminish the mastication function, alter the psychosocial development and the facial aesthetics, cause phonetic disturbances and pain and generate local and systemic infectious complications (Melo et al., 2008) . The effects that tooth decay and apical periodontitis exert on humans have intensified the search for new antimicrobial compounds from other sources, including plants. These novel compounds could aid in controlling oral diseases.
Plants belonging to the genus Copaifera L. (FabaceaeCaesalpinioideae), popularly known as 'copaiba', are native to the tropical regions of Latin America and Western Africa. These trees display a wide range of pharmacological properties, including anti-inflammatory, analgesic, antileishmanial, antimutagenic, gastroprotective and antimicrobial activities (Leandro et al., 2012) .
Among the 20 or more Copaifera spp. found in the Brazilian territory (Leandro et al., 2012) , Copaifera trapezifolia Hayne occurs in one of the most devastated and endangered regions on the planet, the Atlantic Rainforest, where only 12.5 % of the primary vegetation remains [SOS Mata Atlân-tica & INPE (Instituto Nacional de Pesquisas Espaciais), 2015] . Although the Atlantic Rainforest is under major threat, it still contains biologically important areas that deserve protection and expansion to ensure preservation of the species (Milani et al., 2012) .
A phytochemical study on the composition of the essential oil of C. trapezifolia leaves by GC/MS revealed that b-caryophyllene (33.5 %) and germacrene D (10.9 %) are the major constituents of this oil (Veiga et al., 2006) . C. trapezifolia constitutes a large and promising source of bioactive compounds for use in the preventative therapy or treatment of various disorders, including oral diseases. Although literature papers have described the biological action of other Copaifera spp. (Santos et al., 2008; Alves et al., 2013b) , there are no reports on the antimicrobial activity of C. trapezifolia against micro-organisms that cause oral diseases or on the safety of this plant.
The use of medicinal plants, crude plant extracts and isolated compounds for therapeutic purposes requires evaluation of their cytotoxic and mutagenic potential. This is because plant-synthesized substances generally serve as chemical defences against micro-organisms and herbivores and can therefore be toxic to other organisms (Cavalcanti et al., 2006) .
The present study has investigated the antibacterial activity of the hydroalcoholic extract from C. trapezifolia leaves (CTE) against micro-organisms that cause dental caries and apical periodontitis; it has also evaluated the cytotoxicity and mutagenicity of CTE to ensure that it is safe for subsequent application.
METHODS

Plant material
Preparation of the CTE. C. trapezifolia Hayne leaves were collected in the botanical garden of Rio de Janeiro, Brazil, in July 2012. Dr Jos e Silva Costa of the Botanical Garden Herbarium in Rio de Janeiro, Brazil, authenticated the plant material. A voucher specimen was deposited in this same herbarium under number NY 00470875. The leaves were dried at 40 C in an oven operating with circulating air for 36 h. The drying procedure furnished 500 g of dried plant material. The dried leaves were powdered in a knife mill, and 100 g of the leaves was macerated three times in 500 ml of aqueous ethanol 7 : 3 (water/ethanol, v/v), at room temperature, for 48 h. The extracts were combined, concentrated below 40 C under vacuum and lyophilized, to yield 72 g of the crude CTE. 
Antimicrobial assays
Determination of the MIC and minimum bactericidal concentration. MIC was determined by the broth microdilution method, conducted in 96-well microplates; the methodology described by CLSI (2007 CLSI ( , 2009 ) was used. Briefly, CTE samples were dissolved in DMSO (Merck) at 1.0 mg ml
À1
. Then, the samples were diluted in brain-heart infusion broth (Difco) or in Schaedler broth (Difco) supplemented with hemin (5.0 mg ml
) and vitamin K (10.0 mg ml
) in the case of aerobic and anaerobic micro-organisms, respectively. The CTE samples were tested at concentrations ranging from 0.195 to 400 mg ml
. The final DMSO content was 5 % (v/v). DMSO at 5 % (v/v) was the negative control. The inoculum was adjusted at 625 nm in a spectrophotometer to give a cell concentration of 5Â10 5 and 1Â10 6 c.f.u. ml
for aerobic (CLSI, 2009 ) and anaerobic (CLSI, 2007) micro-organisms, respectively. One inoculated well was included to control broth adequacy for micro-organism growth. One non-inoculated well free of antimicrobial agent was also used to ensure medium sterility. Chlorhexidine dichlorohydrate (CHD; Sigma-Aldrich) at concentrations ranging from 0.1 to 59 µg ml
and metronidazole (Sigma-Aldrich) at concentrations ranging from 0.01 to 5.9 µg ml À1 were the positive controls for aerobic micro-organisms and for the anaerobic micro-organisms Bacteroides fragilis (ATCC 25285) and Bacteroides thetaiotaomicron (ATCC 29741), respectively.
The microplates were incubated at 37 C for 24 h for aerobic microorganisms and for 72 h for anaerobic micro-organisms in an anaerobic workstation (Don Whitley Scientific). After that, 30 µl of aqueous resazurin (Sigma-Aldrich) solution at 0.02 % was added to each well. Resazurin is a redox probe that allows immediate observation of microbial growth. Blue and red colours represent absence and presence of microbial growth, respectively (Sarker et al., 2007) .
To determine minimum bactericidal concentration (MBC), an aliquot of the inoculum was aseptically removed from each well without apparent micro-organism growth before resazurin addition. This aliquot was plated onto brain-heart infusion agar supplemented with 5 % sheep blood or onto Schaedler agar in the case of aerobic and anaerobic micro-organisms, respectively. The plates were incubated as described above. MBC was determined for all the investigated bacterial strains.
Time-kill curves
Triplicate time-kill assays were performed according to D'Arrigo et al. (2010) . CTE displayed the highest antibacterial activity (MIC and MBC, 100 µg ml
À1
) against the anaerobic micro-organisms Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate), important causative agents of apical periodontitis (Grenier & Bouclin, 2006; Grenier & La, 2011) . These micro-organisms were chosen for the time-kill curve assays. Tubes containing CTE at a final concentration of 100 µg ml À1 (one time the CTE MIC determined for Porphyromonas gingivalis and Peptostreptococcus micros) were inoculated with the tested micro-organisms at an initial bacterial density of 2.12Â10 5 and 17.2Â10 5 c.f.u. ml À1 for Porphyromonas gingivalis and Peptostreptococcus micros, respectively. After that, the plates were incubated in 5-10 % H 2 , 10 % CO 2 and 80-85 % N 2 atmosphere inside an anaerobic workstation operating at 36 C for 72 h. Aliquots were removed (50 µl) at 0 and 30 min and at 6, 12, 24 and 72 h to count the number of viable colonies after incubation. Next, the aliquots were serially diluted until final dilution of 10 À4 in sterile Schaedler broth. The diluted samples (50 µl) were spread onto Schaedler agar plate and incubated at 36 C; viable colonies were counted after 72 h. Time-kill curves were constructed by plotting log 10 c.f.u. ml À1 versus time with the aid of the Prism software (version 5.0; GraphPad). Assays were performed in triplicate for CTE and also for the positive (CHD) and negative controls (suspension of Porphyromonas gingivalis and Peptostreptococcus micros without added CTE). CHD was used at its MIC (3.688 µg ml À1 for Porphyromonas gingivalis and 7.375 µg ml À1 for Peptostreptococcus micros).
Antibiofilm activity evaluation
The MIC of biofilm (MICB 50 ) was determined based on the lowest CTE concentration that was able to inhibit at least 50 % of biofilm formation. . CHD at concentrations between 0.115 and 59 µg ml À1 was the negative control; the bacterial strains in the absence of the antibacterial agent were the positive control. The Porphyromonas gingivalis or Peptostreptococcus micros cell suspension was added at concentrations of 1Â10 6 c.f.u. ml
À1
. To assess culture growth, absorbance readings were accomplished after 72 h incubation in 5-10 % H 2 , 10 % CO 2 and 80-85 % N 2 atmosphere inside an anaerobic chamber (Don Whitley Scientific) operating at 36 C. Next, the culture supernatant of each well was decanted, and planktonic cells were removed by washing with PBS (pH 7.2). The biofilms were fixed with methanol for 15 min and air dried at room temperature. They were then stained with 0.2 % (w/v) crystal violet (Sigma) for 20 min and rinsed thoroughly with water until control wells became colourless. Biofilm formation was quantified by addition of 150 µl of acetic acid at 33 % to each crystal-violet-stained well. The plates were shaken at room temperature for 30 min; the absorbance at 595 nm (A 595 ) was determined by means of a microplate reader (ASYS; Eugendorf). The percentages of inhibition were calculated by using the equation (1ÀA 595 of the test well/A 595 of non-treated control)Â100 (Wei et al., 2006) .
The antibiofilm activity was also measured by counting the number of micro-organisms. The procedures were the same as the ones described above, but they were conducted on another microplate. After the incubation period, the micro-organisms were counted. Initially, the volume of each well was gently aspirated to remove planktonic cells. To remove non-adhered cells, 200 µl of sterilized Milli-Q water was added and aspirated. Next, 200 µl of supplemented Schaedler broth (Difco) was added, and the microplate was submitted to sonication for 15 min to shed the biofilms. After sonication, the wells were homogenized with the aid of a micropipette. To enable counting, decimal dilutions were accomplished by removing 20 µl aliquots from each well and transferring them to another well containing 180 µl of supplemented Schaedler broth (Difco) in another microplate. Twenty microlitres from this 10 À1 dilution was also transferred to another well to afford a 10 À2 dilution. The same sequence was adopted repeatedly until 10 À7 dilution was achieved. Then, 50 µl of each dilution was seeded with Drigalski spatula in supplemented Schaedler agar plates. This procedure was carried out in triplicate for Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate). The plates were incubated in anaerobic chamber IP: 54.70.40.11
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C for 72 h. Colonies were counted after incubation. The results are expressed as log 10 in c.f.u. ml
. The best inoculum concentration and incubation time for the antibiofilm activity assay were selected by standardizing the biofilm formation (data not shown) (Caetano da Silva et al., 2014).
Synergistic antimicrobial activity
Chequerboard assays were derived from the standard procedure established by CLSI (2007) . These assays helped to investigate the in vitro antimicrobial efficacy of a combination of CHD and CTE against the anaerobic micro-organisms Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate), which were the most susceptible to CTE. The synergy tests were evaluated in triplicate. The combination was algebraically calculated to determine the fractional inhibitory concentration (FIC) index. FIC A was calculated as MIC of drug A in the combination/MIC of drug A alone; FIC B was determined as MIC of drug B in the combination/MIC of drug B alone. The FIC summation ( P FIC) was calculated as: P FIC index=FIC A +FIC B (Chaturvedi et al., 2008) . The P FIC index values were interpreted according to Lewis (2002) . FIC 0.5 and 0.5<FIC<1 corresponded to synergism and additivity, respectively; 1 FIC<4 and FIC!4 referred to indifference and antagonism, respectively.
Salmonella mutagenic assay
The mutagenic activity was also evaluated by the Salmonella/microsome assay also known as the Ames test. This assay used the Salmonella typhimurium tester strains TA98, TA100, TA97a and TA102 with (+S9) and without (ÀS9) metabolization, provided by Dr B. N. Ames (Berkeley, CA, USA). These strains, which were grown from frozen cultures in Oxoid Nutrient Broth No. 2 for 12-14 h overnight, were assessed by the pre-incubation method (Maron & Ames, 1983) .
The metabolic activation mixture (S9 fraction), prepared from livers of Sprague-Dawley rats treated with the polychlorinated biphenyl mixture Aroclor 1254 (500 mg kg À1 ), was purchased from the Molecular Toxicology and freshly prepared before each test. The metabolic activation system consisted of 4 % S9 fraction, 1 % MgCl 2 at 0.4 M, 1 % KCl at 1.65 M, 0.5 % D-glucose-6-phosphate disodium at 1 M, 4 % NADP at 0.1 M, 50 % phosphate buffer at 0.2 M and 39.5 % sterile distilled water (Maron & Ames, 1983) .
To determine the mutagenic activity, five different CTE concentrations (1.56-12.50 mg plate À1 ), diluted in DMSO, were assayed. The CTE concentrations were selected based on a preliminary toxicity test. In all the subsequent assays, the upper limit of the tested dose range was either the highest non-toxic dose or the lowest toxic dose determined in this preliminary assay. Toxicity was detected either as reduction in the number of histidine revertants (His+) or as thinning of the auxotrophic background (i.e. background lawn). DMSO (100 µl plate À1 ) was the negative (solvent) control.
The various tested CTE concentrations were added to 0.5 ml of phosphate buffer at 0.2 M or to 0.5 ml of an S9 mixture at 4 %, which contained 0.1 ml of bacterial culture. Then, the samples were incubated at 37 C for 20-30 min. Next, 2 ml of top agar was added, and the mixture was poured onto a plate containing minimal agar. Subsequently, the plates were incubated at 37 C for 48 h, and His+ revertant colonies were counted manually. All the experiments were carried out in triplicate. The results were analysed with the statistical software package Salanal 1.0 (U.S. Environmental Protection Agency, Monitoring Systems Laboratory, from the Research Triangle Institute); the model of Bernstein et al. (1982) was adopted. The data (revertants/plate) were assessed by ANOVA, followed by linear regression. The mutagenic index (MI) was calculated for each tested concentration. MI corresponded to the average number of revertants per plate containing the test compound (CTE) divided by the average number of revertants per plate containing the negative control (solvent). A test solution was considered mutagenic when a dose-response relationship and a twofold increase in the number of mutants (MI!2) were detected for at least one concentration (Resende et al., 2012) .
Cytotoxicity and mutagenicity assays DNA damage-inducing agents. Methyl methanesulfonate (MMS) was dissolved in PBS (pH 7.4) and used at concentrations of 110 and 44 µg ml À1 for the colony-forming assays and micronucleus (MN) tests on V79 cells, respectively. For the bone marrow MN assays, the animals were treated with 40 mg kg À1 of body weight (BW). In the case of the Ames test, the following standard mutagens were used as positive controls in experiments without the S9 mixture: 4-nitro-o-phenylenediamine (10 µg plate À1 ) for TA98 and TA97a, sodium azide (1.25 µg plate
À1
) for TA100 and mitomycin C (0.5 µg plate À1 ) for TA102. In experiments with S9 activation, 2-amino-anthracene (1.25 µg plate À1 ) was used for TA98, TA97a and TA100; 2-amino-fluorene (10 µg plate À1 ) was used for TA102. The substances were purchased from the Sigma Chemical.
Cell culture conditions
The V79 cells (fibroblasts, Chinese hamster lung) were maintained as monolayers in plastic culture flasks (25 cm 2 ) containing HAM-F10 (Sigma-Aldrich) and DMEM (Sigma-Aldrich, 1 : 1) supplemented with 10 % foetal bovine serum (Nutricell), antibiotics (streptomycin at 0.01 mg ml À1 and penicillin at 0.005 mg ml
À1
, Sigma-Aldrich) and HEPES (Sigma-Aldrich) at 2.38 mg ml
, at 37 C, in a Biochemical oxygen demand (BOD)-type chamber. Under these conditions, the average cell cycle time was 12 h. The experiments were conducted by using V79 cells between the 6th and 12th culture passage after thawing. The V79 cells were used for the cytotoxicity and mutagenicity assessments.
Clonogenic efficiency assay
The clonogenic efficiency assay previously described by Leandro et al. (2013) was used to determine CTE cytotoxicity. The V79 cells were treated with CTE concentrations ranging from 9.70 to 5000 µg ml À1 for 3 h. Positive (MMS, 110 µg ml À1 ) and negative (no treatment) controls were included. Next, the cultures were trypsinized, and 300 cells were seeded per culture flask (three flasks per concentration). The experiments lasted 10 days. The culture medium was removed, and the colonies were washed with PBS and stained with Giemsa (1 : 20 in phosphate buffer, pH 7.0) for 20 min. The colonies were counted under a magnifying glass. The survival fraction (SF) was calculated for the different treatments based on the following formula:
where A is the number of colonies found in the different treatments, and B is the number of colonies found in the negative control (Franken et al., 2006) .
In vitro MN assay
The MN assays were performed according to Resende et al. (2010) and as previously described by Leandro et al. (2013) , with modifications. For the tests, 0.5Â10 6 cells were seeded in tissue culture flasks and incubated in 5 ml of complete HAM-F10/DMEM for two cycles (24 h), followed by washing with PBS (pH 7.4). The cells were then submitted to one of the following treatments in serum-free medium for 3 h: (a) negative control, (b) solvent control (DMSO at 1 %), (c) positive control (MMS at 44 µg ml
À1
) and (d) CTE (at 40, 80, 120 and 160 µg ml
). The CTE concentrations were chosen based on the results obtained during the colony-forming assay; cytotoxicity was used as a selection criterion. At the end of the treatment period, the cells were washed twice with PBS. Next, fresh serum-supplemented medium containing cytochalasin-B (SigmaAldrich) at 3 µg ml À1 was added, and incubation was accomplished for additional 17 h. At harvest, the cells were trypsinized (0.025 %) and treated with a hypotonic sodium citrate solution at 1 % at 37 C. The cells were fixed in methanol/acetic acid (3 : 1), and the slides were stained with Giemsa at 3 % for 5 min. The criteria established by Fenech (2000) were used to analyse MNs and binucleated cells. A total of 3000 binucleated cells were scored per treatment, which corresponded to 1000 cells per treatment per repetition. The nuclear division index (NDI) was determined for the 1500 cells analysed per treatment, for a total of 500 cells per repetition. The cells with well-preserved cytoplasm and containing 1-4 nuclei were scored. The NDI was calculated according to Eastmond & Tucker (1989) ; the following formula was used:
where M1-M4 is the number of cells with 1, 2, 3 and 4 nuclei, respectively, and N is the total number of viable cells.
Additionally, the CTE cytotoxicity index (CI) was calculated according to Kirsch-Volders et al. (2003) :
where NDIT is the NDI found for the different treatments, and NDIC is the NDI of the negative control. The mutagenicity assay comprised three totally independent experiments.
In vivo MN assay
Male Swiss mice (7-8 weeks old) weighing approximately 25 g were provided by the Faculty of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. The animals were kept in plastic boxes in an experimental room under controlled temperature (22±2 C) and humidity (50±10 %) in a 12 h light/dark cycle, with standard mouse chow and water available ad libitum. The Ethics Committee for Animal Care of the University of Franca (protocol 001/14) approved the study protocol.
The study animals were divided into different experimental groups of six animals each. The different CTE doses (125, 250, 500, 1000 and 2000 mg kg À1 BW) were administered by gavage (0.5 ml per animal). Negative (water), solvent (DMSO at 0.5 µg ml
À1
) and positive (intraperitoneal MMS at 40 mg kg À1 of BW, 0.3 ml per animal) control groups were included. The bone marrow samples were collected 24 h after treatment.
The bone marrow MN assays were performed according to the protocol described by MacGregor et al. (1987) . A total of 2000 polychromatic erythrocytes (PCEs) were analysed per animal to determine the frequency of micronucleated polychromatic erythrocytes (MNPCEs). The PCE/PCE+NCE (normochromatic erythrocytes) ratio was calculated by analysis of 400 erythrocytes for determination of the cytotoxicity (Mersh-Sundermann et al., 2004) . The slides were scored blindly by using a light microscope with a Â100 objective immersion.
Statistical analysis
The results obtained during the MN assays were evaluated by ANOVA for completely randomized experiments, with calculation of F statistics and the respective P values. When P<0.05, the treatment means were compared by the Tukey test, and the minimum significant difference was calculated for a=0.05.
RESULTS
HPLC chromatographic analysis of the crude CTE
Comparison with authentic standards showed that the compounds with retention times of 41 and 47 min corresponded to quercitrin and afzelin, respectively. The profiles of the other major compounds detected in CTE were also compatible with the profile of phenolic compounds (Fig. 1) .
MIC and MBC
We considered that MIC values higher than 400 µg ml À1 , the highest CTE concentration used in this study, corresponded to lack of antibacterial action. We determined the MIC value for CHD against Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate), the bacteria that were the most susceptible to CTE. These results were important for the time-kill assay and for evaluation of the synergistic antimicrobial activity (Table 1) .
Time-kill assay
Regarding Porphyromonas gingivalis (ATCC 33277), CTE at a concentration of 100 µg ml À1 started to progressively diminish the number of micro-organisms at 48 h incubation; the bactericidal action was evident at 72 h (Fig. 2b) . As for Peptostreptococcus micros (clinical isolate), CTE at a concentration of 100 µg ml À1 reduced the number of micro-organisms by over 3 log 10 at 30 min. The number of micro-organisms continued to decrease progressively until 48 h incubation, and the bactericidal activity clearly emerged at 72 h incubation (Fig. 2a) .
CHD (3.688 µg ml
À1
), used as positive control for Peptostreptococcus micros (clinical isolate) and Porphyromonas gingivalis (ATCC 33277), reduced the number of microorganisms at 48 h incubation and exhibited bactericidal activity at 72 h incubation (Fig. 2a, b) .
Antibiofilm activity
Analysis of the OD and of the number of micro-organisms (log 10 c.f.u. ml
À1
) demonstrated the antibiofilm activity of CTE and CHD. The MICB 50 helped us to evaluate the CTE antibiofilm activity. The graphs in Fig. 3(a, c) illustrate the MICB 50 results for CTE and CHD against Peptostreptococcus micros (clinical isolate) and Porphyromonas gingivalis (ATCC 33277), respectively. At a concentration of 29.5 µg ml À1 , CHD inhibited Peptostreptococcus micros and Porphyromonas gingivalis biofilm formation by at least 50 % (Fig. 3b, d , respectively). At a concentration of 200 µg ml
, CTE inhibited Peptostreptococcus micros and Porphyromonas gingivalis biofilm formation by at least 50 % (Fig. 3a, c, respectively) .
Synergistic antimicrobial activity
The combination of CTE with CHD did not elicit any synergistic effects. The SFIC indices of 2.24 and 11.98 for Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate) indicated an indifferent effect and an antagonistic effect, respectively. Table 2 presents the mean number of revertants/plate (M), the SD and the MI obtained after treatment of the Salmonella typhimurium strains TA98, TA100, TA102 and TA97a with CTE in the presence (+S9) and absence (ÀS9) of metabolic activation. Compared with the negative control, CTE did not increase the number of revertant colonies, which attested to lack of mutagenic activity. Fig. 4 displays the dose-dependent changes in the viability of V79 cells treated with CTE as evaluated by the colonyforming assay. The cultures treated with CTE at 9.7, 19.5, 39.0 and 78.1 µg ml À1 did not differ significantly from the negative control. In contrast, the cultures treated with CTE at 156.2, 312.5, 625, 1250, 2500 and 5000 µg ml À1 were significantly different from the negative control, which revealed a cytotoxic effect. Therefore, we used CTE at 40, 80, 120 and 160 µg ml À1 for the in vitro MN test (Table 3) . exhibited significantly higher MN frequencies as compared with the negative control. Hence, CTE was mutagenic at these concentrations. Compared with the negative control, NDI was not significantly different in any of the treated groups. Therefore, cytotoxicity did not emerge under the experimental conditions of the treatments applied herein. The animals treated with distinct CTE doses did not have significantly different MNPCE frequency as compared with the negative control, which demonstrated the absence of mutagenic activity. According to Leandro et al. (2012) , although many species of Copaifera have been described, only nine of these species have been the object of biological studies, which have evaluated their traditional uses in folk medicine. Some researchers have not specified which Copaifera spp. they investigated. C. langsdorffii, Copaifera lucens, Copaifera martii, Copaifera multijuga, Copaifera officinalis, Copaifera paupera, Copaifera reticulata, Copaifera duckei and Copaifera cearensis are the most often evaluated species. To our knowledge, there are no literature reports on the biological action of C. trapezifolia. Therefore, the present study aimed to evaluate the antimicrobial activity of C. trapezifolia CTE against causative agents of dental caries and apical periodontitis.
Salmonella mutagenic assay
Cytotoxicity assay
In vitro MN test
In vivo MN assay
Oral diseases affect 3.9 billion people worldwide (Marcenes et al., 2013) . Dental treatment is usually very expensive and not readily accessible, especially in developing countries (More et al., 2008) . Copaifera spp. constitute a rich and promising source for the discovery of novel biologically active compounds with potential use in preventative therapies and in the treatment of oral diseases (Pieri et al., 2010; Souza et al., 2011a, b) . In this sense, the search for new antimicrobial substances from other sources (including plants) for incorporation into dental products has intensified.
It is now widely accepted that a myriad of bacteria, and not a single micro-organism, underlie dental caries and periodontal diseases. On the tooth surface, for example, the main early or primary colonizers are streptococci and actinomyces, which underlie dental caries. CTE exhibited antibacterial activity at concentrations ranging from 200 to 400 µg ml À1 against some of these colonizers. In turn, the onset of periodontal tissue inflammation is triggered by colonization of the subgingival region by periodontal bacteria. Over time, the proportions of Gram-positive facultative anaerobic bacteria decrease, and Gram-negative anaerobes eventually become more established, especially at the interface between the teeth and gums (Jenkinson & Lamont, 2006; How et al., 2016) . F. nucleatum, which plays a crucial role as bridging micro-organism between early and late colonizers, and Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, which are late colonizers, represent a portion of the climax community in the biofilms at sites that exhibit the disease (Kolenbrander et al., 2002; Holt & Ebersole, 2005; Park et al., 2014) . Alone, none of these microbial species cause the destructive events involved in periodontal disease progression. This is because the aetiology requires concerted interaction among these members so that they can establish their niches in the oral cavity (Marcotte & Lavoie, 1998; Maiden et al., 2003; Paster et al., 2006; How et al., 2016) . CTE exhibited antibacterial activity against some of these colonizers, e.g. F. nucleatum (ATCC 25586 and clinical isolate), A. naeslundii (clinical isolate), Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate), with MIC and MBC ranging from 100 to 400 µg ml
À1
. CTE displayed different antimicrobial activities against the Porphyromonas gingivalis strains (ATCC 33277 and clinical isolate). Experiments in laboratory use pure cultures with well-known characteristics, which greatly contrasts with real-world environments. In vivo, bacteria have developed elaborate strategies to cope with particular habitats, which has resulted in significant genetic diversity within one species. In the course of sequential in vitro passage, laboratory reference strains might have significantly differentiated features as compared to non-passaged clinical samples. Therefore, any research conducted based on current laboratory strains and their genome sequence could miss important pathophysiological mechanisms that are only present in clinical strains (Fux et al., 2005) . Another issue is that wild strains (clinical isolates) are generally more resistant to antimicrobials because they are more likely to have contact with different compounds (selective pressure). In contrast, standard strains do not undergo this type of selective pressure and thus experience fewer genetic alterations, which confer them with higher sensitivity to antimicrobials. Here, the Porphyromonas gingivalis (ATCC) standard strain confirmed these assumptions: they were more sensitive to CTE than the clinical isolate.
In the present study, we did not detect CTE antibacterial activity against Prevotella buccae (clinical isolate), which could be due to interactions between phenolic compounds present in CTE and these micro-organisms. Only the isolation of these compounds and new antibacterial assays could clarify these results and the mechanisms of action of the compounds.
As for the results obtained for CHD against the cariogenic bacteria evaluated herein, this gold standard appears to be the most effective antimicrobial agent as judged from its bactericidal and bacteriostatic effects and its long-lasting action within the oral cavity (8 h after rinsing). However, the various adverse effects of CHD limit the long-term use of this antiseptic agent including taste alteration, excess formation of supragingival calculus, soft-tissue lesions in young patients, allergic responses and staining of teeth and soft tissues (Najafi et al., 2012) . These problems, therefore, denote that finding new effective and safe antibacterial compounds is essential. CTE constitutes a large and promising source of bioactive compounds that may be used to develop new oral products. In the future, the CTE could be applied to the oral cavity in isolation or associated with CHD to fight against potentially pathogenic micro-organisms. Santos et al. (2008) used the microdilution technique to test the antimicrobial activity of copaiba oils against Grampositive bacteria, namely Staphylococcus aureus (ATCC 25923), Bacillus subtilis (ATCC 6623), Staphylococcus epidermidis (ATCC 12228), methicillin-resistant Staphylococcus aureus ATCC 33591 and E. faecalis (ATCC 29212). The oils of C. martii, C. officinalis, C. reticulata, C. cearensis, C. paupera, C. langsdorfii , C. multijuga and C. lucens exhibited antibacterial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, with MIC ranging from 62.5 to 1000 µg ml
. It is noteworthy that most studies on Copaifera spp. concern the trunk resin oil; few studies have dealt with their aerial parts. The hydroalcoholic extract from C. langsdorffii leaves has potential application in the treatment of urolithiasis , exerts a protective effect against doxorubicininduced chromosome damage (Alves et al., 2013b) , potentially prevents kidney stone formation (de Oliveira et al., 2013) and displays chemopreventative action against colon cancer (Senedese et al., 2013) . These data denote the importance of investigating other Copaifera extracts, including CTE.
By means of time-kill assays, Santos et al. (2008) examined the action of C. martii resin oil against Staphylococcus aureus. Time-kill curves evidenced that no viable cells remained after 3 h of treatment with copaiba oil at twice the MIC (125 µg ml
) value. The time-kill assays conducted for CTE against anaerobic micro-organisms revealed that Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate) were the most susceptible to CTE (Table 1) . At 100 µg ml
, CTE exerted a bactericidal effect against Porphyromonas gingivalis within 72 h. As for Peptostreptococcus micros, CTE at 100 µg ml À1 reduced the number of microorganisms by over 3 log 10 at 30 min and exhibited bactericidal activity at 72 h incubation. According to Petersen et al. (2004) , bactericidal activity corresponds to a reduction of 99.9 % (!3 log 10 ) in the total number of c.f.u. ml À1 in the original inoculum, whereas bacteriostatic activity refers to maintenance of the original inoculum concentration or reduction of less than 99.9 % (<3 log 10 ) in the total number of c.f.u. ml À1 in the original inoculum.
Dental biofilm formation is the most important factor in the aetiology of caries and apical periodontitis. These biofilms are more resistant to antimicrobial agents as compared with planktonic cells (Stewart & Costerton, 2001) . Antibiofilm substances can inhibit biofilm formation (preventative effect) or act on biofilms that have already emerged (therapeutic effect) (Alves et al., 2013a) . OD analysis and counting of the number of micro-organisms (log 10 c.f.u. ml
) provided reliable results for evaluation of the antibiofilm activity of CTE and CHD. At 200 µg ml
, CTE inhibited Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate) biofilm formation by at least 50 %. Bearing in mind that biofilms tend to be 10-1000 times more resistant to antimicrobial agents as compared with the planktonic state (Ramage et al., 2001) , the assay conducted in the present study, which used biofilms consisting of a single species, may have had its limitations. According to Park et al. (2014) , multi-species biofilms mimic the condition of the oral cavity more closely as compared to single-species biofilms. Therefore, multispecies biofilms offer many advantages. First, they minimize the possibility of contamination and increase reproducibility. Second, they form a thicker biofilm and more complex networks than single-species biofilms. Third, they are more resistant to antibiotics than single-species biofilms. However, even though our assay had limitations because it only evaluated single-species biofilms, we understand that eliminating micro-organisms present as planktonic cells is necessary and important to avoid biofilm formation. In this sense, the results reported herein are extremely relevant: they demonstrate the potential use of Copaifera spp. as antibiofilm agents incorporated into dental products (Cai & Wu, 1996; Ambrosio et al., 2008) as a means to complement mechanical biofilm removal from the oral cavity and to reduce the incidence of oral diseases in humans (Allaker & Douglas, 2008; More et al., 2008) .
Because of lack of papers on other Copaifera spp., we had difficulty comparing the results from the assessment of the synergistic antimicrobial activity of CTE and CHD with data from other works. However, in a study with (À)-copalic acid, a diterpene that serves as biomarker of the genus Copaifera (Leandro et al., 2012) , Souza et al. (2011a) determined the synergistic antimicrobial activity of (À)-copalic acid isolated from C. langsdorffii. Together, CHD and (-)-copalic acid had indifferent effect on Streptococcus mutans, a bacterium that underlies the start of the caries process; the P FIC index was 2.02. Here, CTE did not act synergistically with CHD. The P FIC indices of 2.24 and 11.98 obtained for Porphyromonas gingivalis (ATCC 33277) and Peptostreptococcus micros (clinical isolate) characterized an indifferent effect and an antagonistic effect, respectively. To our knowledge, this is the first work that has investigated the synergistic antimicrobial action of C. trapezifolia.
According to Palombo (2011) , plant extracts, essential oils and purified phytochemicals can be potentially applied in preventative therapy or treatment of oral diseases. Nevertheless, assessment of the safety and efficacy of these agents is crucial to establish whether they offer therapeutic benefits. Therefore, another aim of this study was to evaluate the cytotoxic and mutagenic potential of CTE.
The colony-forming assay showed that CTE was cytotoxic at concentrations equal to or higher than 156.2 µg ml
. A study by Masson-Meyers et al. (2013) provided data on the cytotoxicity of the C. langsdorffii resin oil. Increasing copaiba resin oil concentrations decreased the viability of fibroblasts. However, even at the highest tested resin oil ). *Significantly different from the negative control group (P<0.05). concentrations (500 µg ml À1 and 1000 µg ml
), 70 % of the cells remained viable as compared with the control, which attested that copaiba resin oil has low toxicity. Herein, CTE was cytotoxic at concentrations equal to or higher than 156.2 µg ml
. This may be attributed to the fact that the chemical composition of Copaifera leaves differs from the chemical composition of the trunk resin oil, which are rich in phenolic compounds and terpenoids, respectively (Alves et al., 2013a) .
The Salmonella mutagenic assay revealed no gene mutations in the presence of CTE, regardless of metabolic activation. The fact that CTE had no mutagenic effects on Salmonella typhimurium bacterial strains during the Ames test is a positive step towards ensuring its safe use in medicine. Considering the popular use of Copaifera plants, the lack of mutagenic effects in bacteria is highly relevant. The Salmonella mutagenic assay is used worldwide for initial screening of the mutagenic potential of new chemicals and drugs (Adzu et al., 2015; Uysal et al., 2016) . In this assay, a mutagenic response has high predictive value for rodent carcinogenicity. Over the years, the scientific community as well as government agencies and corporations (McCann et al., 1975; Sugimura et al., 1976; Zeiger, 1985; Zeiger et al., 1990) have recognized the value of this assay, which constitutes an excellent tool to assess the safety of extracts, oils and phytochemicals isolated from Copaifera spp.
MN tests on V79 cells evidenced a mutagenic effect for CTE at the two highest tested concentrations. However, in vivo MN tests did not show any mutagenicity at the tested CTE concentrations. Copaifera leaves are rich in phenolic compounds (Alves et al., 2013b) . According to Ferguson (2001) , even phenolic compounds that test negative in bacterial assays may be clastogenic in the case of mammalian cells. Indeed, CTE displayed no mutagenicity in the Salmonella mutagenic assay, but it was mutagenic in the MN test conducted on V79 cells. This mutagenicity may be at least partly due to the presence of phenolic compounds in Copaifera leaves.
Phenolic compounds occur naturally in a range of plants, many of which have antioxidant, antimutagenic, antiestrogenic, anticarcinogenic and anti-inflammatory properties that might prevent disease and protect genome stability. Unfortunately, not all these compounds, and not all the actions of individual phenolic compounds, are necessarily beneficial. In fact, some of these compounds have mutagenic and/or pro-oxidant effects (Ferguson, 2001 ).
Additionally, CTE was not mutagenic as revealed by the in vivo MN test. Alves et al. (2013b) did not find any mutagenic effect for the hydroalcoholic extract of C. langsdorffii leaves in the in vivo MN test, either. CTE metabolization may underlie the absence of CTE mutagenicity during in vivo assays. Several studies have shown that phenolic compounds are extensively metabolized in vivo, mainly in the liver. These compounds also undergo metabolization by colonic microflora during transfer across the small intestine. These metabolic processes result in significant alteration in redox potentials (Day & Williamson, 2003; Donovan & Waterhouse, 2003) . After undergoing phase I deglycosylation, phenolic aglycones are converted to glucuronides, sulfates and o-methylated derivatives during phase II metabolism (Schroeter et al., 2002) .
Because very few natural products are known to inhibit the growth of oral pathogens (Saleem et al., 2010) and studies on the safety of these extracts are scarce (Palombo, 2011) , this is an important report on the antibacterial action of the CTE against causative agents of dental caries and apical periodontitis.
In conclusion, our study has demonstrated that CTE exhibits antibacterial activity against some of the tested microorganisms under the experimental conditions used. Although CTE at higher concentrations displayed in vitro cytotoxicity and mutagenicity, it was not mutagenic during the Salmonella mutagenic assay and the MN test in vivo. Hence, this plant species can be an important source of biologically active compounds and aid in the search for new effective and safe agents that act against oral pathogens.
